An interventional study of Ballistic Resistance Lower Body Strength Training and Conventional Resistance Lower Body Strength Training in Osteoporosis and Osteoarthritis, sponsored by Loughborough University. Active, not recruiting at 1 site in United Kingdom. Open to female participants aged 50 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-21.
Sponsored by Loughborough University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 57 studies in Osteoporosis with a site in United Kingdom — 8 open to participants now, 9 under way, none of them phase 3. Osteoporosis · United Kingdom.
Among the 57 studies in Osteoporosis with a site in United Kingdom, this one is the 18th largest by planned enrollment of the 35 interventional ones that give a count, is one of 2 that started in 2022, is one of 15 with no phase, and was the 46th registered.
1,602 studies on the registry are indexed under Osteoporosis; 209 are open to participants now.
Browse Osteoporosis studies →8 of the 57 studies in Osteoporosis with a site in United Kingdom are open now. Recruiting first, the newest first:
AO Foundation, AO Spine · Sites in United Kingdom, United States, Argentina and 11 more countries
Ages 50+
Promedius Inc · Sites in United Kingdom, Netherlands
Ages 50+ · Healthy volunteers
Bradford Institute for Health Research · Sites in United Kingdom
Ages 70+
King's College London · Sites in United Kingdom
Ages 18+
Relation Therapeutics · Sites in United Kingdom
Ages 18–110
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 133 Osteoporosis studies recruiting now, 77 (58%) set no upper age limit and 20 (15%) stop at 75 or younger; 9 take children under 18; 36 take healthy volunteers.
This study: 50 Years to 70 Years · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
57 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 5 · Phase 3 11 · Phase 4 4
First in 1992; this study’s year is marked. 2 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 110 is above the median of 88 across 1,084 interventional studies indexed under Osteoporosis.
Median enrollment 110 across the 35 interventional studies, 440 across the 21 observational. Of the 37 that completed or were terminated, 8 (22%) have results posted.
This tab as a report to print or save as PDF → With an account.
17 of 57 have an industry lead sponsor. The 10 most frequent:
Loughborough University is the lead sponsor of 76 studies on the registry; 13 are open to participants now.
Loughborough University has 3 studies filed under Osteoporosis — fewer than ten, so there is no comparison to draw.
3 of the studies in Osteoporosis with a site in United Kingdom that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07421713Promedius IncA Study Evaluating the Performance of Using AI Software and Chest X-rays to Screen for Osteoporosis as Compared to Standard DXA Scans in Patients 50 Years and Older | 2026-11-30 |
| NCT05889598Loughborough UniversityResistance Exercise Training to Improve Bone and Articular Cartilage Health in Women | 2026-12-31 |
| NCT04796350AgNovos Healthcare, LLCRESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures | 2027-04-01 |
Add all 3 to your calendar (.ics) → With an account.
Among the 57 studies in Osteoporosis with a site in United Kingdom, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Osteoarthritis (degenerative joint disease) and osteoporosis (weak and fragile bones) are common conditions, particularly in women after menopause, and become even more common as we get older. Aging is also associated with sarcopenia, the progressive loss of muscle strength and mass with age. In this three-arm study, the effect of resistance exercise programs with different parameters (such as velocity and load) on various outcomes, including structural changes (bone mineral density, cartilage composition, muscle size), physical function, and biomarkers will be compared.
Resistance exercise is effective in improving several risk factors for osteoporosis and osteoarthritis, and is recommended to prevent and manage both conditions, and is also known to counteract sarcopenia. Overall, there is little and inconsistent evidence on the effects of exercise parameters (such as velocity) for the prevention of osteoporosis and osteoarthritis, neither is there a comparison of different velocities on structural parameters and biomarkers. Although osteoporosis and osteoarthritis take a long time to develop, it is possible to look at changes in risk using scans of bones and joints -Dual-Energy X-ray absorptiometry (DXA), peripheral Quantitative Computed Tomography (pQCT), and Magnetic Resonance Imaging (MRI)-, blood and/or urine samples and symptoms.
This study aims to examine the effect of two different resistance exercise interventions (explosive high-velocity vs high-load low-velocity training) on structural changes on bone, articular knee and/or hip cartilage and muscle, as well as biomarkers.
The study will be a 32-week long randomized controlled trial including two exercise groups and one non-exercising control group.
Screening and baseline measurements will then be taken when anonymization is completed. Once participants have completed baseline testing, participants will be randomly assigned to one of the exercise groups or control groups using a block randomization technique. Participants will choose an envelope, prepared in batches of 11, which will contain a note saying either 'ballistic' or 'conventional or 'control' with a ratio of 4:4:3. This is to allow for greater drop-out in the exercise groups. It is not possible to blind the participant or researchers supervising the intervention to the group allocation.
The required exercise program involves two supervised sessions per week at Loughborough University, each lasting no longer than 60 minutes per session. Each session will involve 30-40 minutes of exercise and time to check any symptoms or queries with participants.
The exercises are designed to strengthen major muscle groups of the trunk and lower body, as well as to load bones that are affected by osteoporosis and the knee and hip joints that are commonly affected by osteoarthritis. Each exercise training session will take 30-40 minutes and include some whole-body warm-up and trunk exercises before completing the two main exercises: a hack squat and calf raise. These two main exercises will be done using resistance (weight training) machines in a dedicated exercise facility. Investigators chose a hack squat machine as it exercises many muscle groups and skeletal sites in one exercise, including the spine and lower limb rather than a small area. Additionally, it supports the spine, making it safe and comfortable to use.
The intervention will be personalized to the individual's ability, and loads will steadily increase as the participant improves. The load will be decided according to maximal muscular strength determined by calculation of 1-repetition maximum which will be renewed every month to monitor the progress of their muscle strength and use of the correct weight for training (in proportion to the strength). Participants will start off using light weights and these will increase as participants become stronger.
The two exercise groups will follow the same exercise programmes but using different speeds and weights: The conventional training group will perform the exercises slowly (conventionally), whilst the ballistic group will use lower loads and higher velocity as if trying to jump. Participants will be carefully guided and coached to perform all the exercises correctly and all the exercise training sessions will be supervised by qualified researchers to ensure safety throughout the study.
The control group will be asked to maintain their usual exercise and diet. Follow-up measurements will take place 16 and 32 weeks after the commencement of the exercise programme.
The sample size calculation is based on detecting differences in bone mineral density between each exercise group and the control group. Using an effect size of 0.75 (considered clinically meaningful), alpha of 0.05, and beta errors of 0.95, approximately 28 participants are needed for each group. However, the final sample size should cover a possible number of withdrawals. To allow for a 30% drop-out rate in exercise groups, 110 participants will be recruited for the study.
All data will be reported in the final work; any missing data will be accounted for with reasons for it missing. All measures described in the methodology will be reported, whether results are statistically significant or not. Data from all eligible participants will be included in an intention-to-treat analysis. Multiple imputation will be used for addressing the presence of missing data. The analysis will be repeated in good adherers i.e. those who attended at least 90% of the exercise sessions.
Descriptive statistics will be calculated to give information on mean values and variation (standard deviation) of the cohort. Normal distribution will be analysed using Shapiro-Wilk test. If variance is shown to be homogenous and distribution normal within the population then repeated measures analysis of variance (RM-ANOVA) will detect any significant differences between group (exercise versus control), time (baseline versus post-intervention) or group x time interaction.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
This arm will perform the exercises in a hack squat machine using low loads and explosive high-velocity (as if trying to jump)
Other: Ballistic Resistance Lower Body Strength Training
This arm will perform the exercises in a hack squat machine using high-load and low-velocity (conventional training)
Other: Conventional Resistance Lower Body Strength Training
Continue usual life
The exercise programme involves two supervised sessions per week at University. Each session will involve 30-40 minutes of exercise, comprising warm-up , two main exercises: a hack squat and calf raise using a hack squat machine, and core exercises. After a warm-up period involving 5 minutes cycling and one set of 5 conventional repetitions at 40%1RM, the ballistic training group will complete eccentric phase hack squat exercise in approximately 3 seconds and the concentric phase as fast as possible with throwing type contractions. If participants can, participants will be allowed to take off in the concentric phase. To maintain high velocity in this group, lower loads will be used compared to the conventional group. The load will be decided according to regular maximal muscular strength test (1RM) to use of the correct weight for training (in proportion to the strength). Participants will start off using light weights and these will increase as participants become stronger.
The exercise programme involves two supervised sessions per week at Loughborough University. Each session will involve 30-40 minutes of exercise, comprising warm-up , two main exercises: a hack squat and calf raise using a hack squat machine, and core exercises. After a warm-up period involving 5 minutes cycling and one set of 5 conventional repetitions at 40% of 1RM, the conventional training group will complete eccentric and concentric phases of hack squatting exercises for approximately 3 seconds each, with appropriate breathing techniques. The load will be decided according to regular maximal muscular strength test (1RM) to use of the correct weight for training (in proportion to the strength). Participants will start off using light weights and these will increase as participants become stronger.
Change in Femoral neck bone mineral content from baseline
(g) measured by DXA
Time frame: 32nd week
Change in Femoral neck bone mineral density from baseline
(g/cm\^2) measured by DXA
Time frame: 32nd week
Bone Mineral Content (Femur)
Proximal Femur bone will be assessed in "g" by DXA
Time frame: Baseline, 16th and 32nd weeks
Bone Mineral Density (Femur)
Proximal femur bone will be assessed (g/cm\^2) by DXA
Time frame: Baseline, 16th and 32nd weeks
Bone Mineral Content (Spine)
Lumbar spine bone will be assessed (g) by DXA
Time frame: Baseline, 16th and 32nd weeks
Bone Mineral Density (Spine)
Lumbar spine will be assessed (g/cm\^2) by DXA
Time frame: Baseline, 16th and 32nd weeks
bone mineral content (Forearm)
Forearm bone will be assessed (g) by DXA
Time frame: Baseline, 16th and 32nd weeks
bone mineral density (Forearm)
Forearm bone will be assessed (g/cm\^2) by DXA
Time frame: Baseline, 16th and 32nd weeks
Bone mineral content (Lower leg)
Tibia bone will be assessed (g) by DXA
Time frame: Baseline, 16th and 32nd weeks
bone mineral density (Lower Leg)
Tibia bone will be assessed (g/cm\^2) by DXA
Time frame: Baseline, 16th and 32nd weeks
Bone mineral content (Total body)
Whole body will be assessed (g) by DXA
Time frame: Baseline, 16th and 32nd weeks
bone mineral density (Total Body)
Whole body will be assessed (g/cm\^2) by DXA
Time frame: Baseline, 16th and 32nd weeks
cortical bone subdensity (Forearm)
Radius bone 4% (mg/cm\^3) measured by pQCT
Time frame: Baseline, 16th and 32nd weeks
total bone density (Forearm)
Radius bone 4% (mg/cm\^3) measured by pQCT
Time frame: Baseline, 16th and 32nd weeks
trabecular bone density (Forearm)
Radius bone 4% (mg/cm\^3) measured by pQCT
Time frame: Baseline, 16th and 32nd weeks
bone total density (Forearm)
Radius bone 66% (mg/cm\^3) measured by pQCT
Time frame: Baseline, 16th and 32nd weeks
cortical bone density (Forearm)
Radius bone 66% (mg/cm\^3) measured by pQCT
Time frame: Baseline, 16th and 32nd weeks
total bone density (Lower leg)
Tibia bone 4% (mg/cm\^3) measured by pQCT
Time frame: Baseline, 16th and 32nd weeks
trabecular bone density (Lower leg)
Tibia bone 4% (mg/cm\^3) measured by pQCT
Time frame: Baseline, 16th and 32nd weeks
cortical bone subdensity (Lower leg)
Tibia bone 4% (mg/cm\^3) measured by pQCT
Time frame: Baseline, 16th and 32nd weeks
bone total density (Lower leg)
Tibia bone 38% (mg/cm\^3) measured by pQCT
Time frame: Baseline, 16th and 32nd weeks
cortical bone density (Lower leg)
Tibia bone 38% (mg/cm\^3) measured by pQCT
Time frame: Baseline, 16th and 32nd weeks
total bone density (66% of Lower leg)
Tibia bone 66% (mg/cm\^3) measured by pQCT
Time frame: Baseline, 16th and 32nd weeks
cortical density (Lower leg)
Tibia bone 66% (mg/cm\^3) measured by pQCT
Time frame: Baseline, 16th and 32nd weeks
T2 relaxation time
Knee joint cartilage (ms) measured by MRI
Time frame: Baseline and 32nd week
cartilage thickness
Knee joint cartilage (mm) measured by MRI
Time frame: Baseline and 32nd week
Change in bone turnover markers (CTX-1 and PINP) in bodily samples
Serum/urine will be analysed by ELISA kits
Time frame: Baseline, 16th and 32nd weeks
Change in serum biomarkers (OPG, DKK1, irisin, IL-6, C2C, PIICP) in serum samples (exploratory, post hoc)
Additional serum biomarkers, including osteoprotegerin (OPG), dickkopf Wnt signalling pathway inhibitor 1 (DKK1), irisin, interleukin-6 (IL-6), type II collagen cleavage neoepitope (C2C), and procollagen type II C-propeptide (PIICP), were assessed by ELISA kits. These biomarkers were not pre-specified in the original trial registration. Blood samples had been collected during the study period prior to database lock. The decision to include these biomarkers was made after trial completion, and analyses are considered exploratory.
Time frame: Baseline, 16th and 32nd weeks
Lower limb power
(W) measured during Hack squat action
Time frame: Baseline, 16th and 32nd weeks
Lower limb force
(N) measured during Hack squat action
Time frame: Baseline, 16th and 32nd weeks
Lower limb velocity
(m/s) measured during Hack squat action
Time frame: Baseline, 16th and 32nd weeks
Quadriceps cross-sectional area
(cm\^2) measured by MRI
Time frame: Baseline and 32nd week
Triceps surae cross-sectional area
(cm\^2) measured by pQCT
Time frame: Baseline and 32nd week
Lower extremity functioning
(total score in points) using Short Physical Performance Battery. SPPB scores range from zero to 12 possible points. SPPB score of 10 or greater for persons with no mobility disability indicates robustness.
Time frame: Baseline, 16th and 32nd weeks
Mobility/agility
The timed Up and Go test is rated on a scale from 1 to 5 where 1 indicates "normal function" and 5 indicates "severely abnormal function"
Time frame: Baseline, 16th and 32nd weeks
Pain, symptoms, activities of daily living, sport and recreation function, and knee-related quality of life following knee injury
the Knee Injury and Osteoarthritis Outcome Score (KOOS) questionnaire will be used for that. A Likert scale is used and all items have five possible answer options scored from 0 (No Problems) to 4 (Extreme Problems) and each of the five scores is calculated as the sum of the items included. Scores are transformed to a 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems
Time frame: Baseline, 16th and 32nd weeks
Pain, stiffness, and physical function of the hip and knee
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) questionnaire The test questions are scored on a scale of 0-4, which correspond to: None (0), Mild (1), Moderate (2), Severe (3), and Extreme (4). The scores for each subscale are summed up, with a possible score range of 0-20 for Pain, 0-8 for Stiffness, and 0-68 for Physical Function. Usually a sum of the scores for all three subscales gives a total WOMAC score, however there are other methods that have been used to combine scores. Higher scores on the WOMAC indicate worse pain, stiffness, and functional limitations.
Time frame: Baseline, 16th and 32nd weeks
Physical Activity Level
Bone-specific Physical Activity Questionnaire (BPAQ). higher scores mean higher physical and better outcomes for the study
Time frame: Baseline, 16th and 32nd weeks
Physical activity and inactivity level
International Physical Activity Questionnaire (IPAQ)
Time frame: Baseline, 16th and 32nd weeks
Daily calcium intake
(mg) Calcium Questionnaire
Time frame: Baseline, 16th and 32nd weeks
Static postural sway
anterior-posterior and medial-lateral mean velocity (cm/s) of the centre of pressure
Time frame: Baseline, 16th and 32nd weeks
Static postural sway (elliptical area)
the elliptical area (cm\^2) will be assessed
Time frame: Baseline, 16th and 32nd weeks
Started Mar 2022 (actual). Primary completion is estimated for Dec 2026, 57 months after the start.
Of 220 non-industry interventional studies with no phase under Osteoporosis, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 49. This study's planned 57 months is above that.
Counting every sponsor, half of 239 studies reached it within 26 months; a quarter within 9 and three quarters within 50.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Loughborough University